Joint Injections for Dogs: Types, Cost, Evidence & Risks

Joint injections for dogs are veterinary procedures in which a substance is placed directly into an arthritic joint, under sedation, to reduce pain and improve limb use. The options a US vet may offer are corticosteroids, hyaluronic acid, platelet-rich plasma (PRP), autologous protein solution (Pro-Stride), stem cells, polyacrylamide hydrogel (Arthramid Vet) and tin-117m radiosynoviorthesis (Synovetin OA). Only one injectable arthritis product for dogs is FDA-approved - Adequan Canine - and it is not injected into the joint at all.

That last detail is where most articles on joint injections for dogs go wrong. Below is what the peer-reviewed veterinary literature reports for each option - study size, what was measured, how long the effect lasted, where the evidence runs out - plus realistic US prices, what sedation involves, and a decision frame for choosing between an injection and daily management.

How safe are joint injections in dogs?

This is the best-answered question in the whole topic. A retrospective review at Cornell University Hospital for Animals covering 505 joint injections across 283 visits in 178 client-owned dogs between 2010 and 2022 found (Miller et al., JAVMA 2023, PMID 36595365):

• Transient soreness in 18.4% of visits, median duration 2 days (range 1-20 days).
• Gastroenteritis in 6.8%.
• Septic arthritis in 1 of 505 joints (0.2%) - the only potential major complication recorded.
• Soreness was unrelated to how many joints were injected in one visit. Larger injectate volumes relative to body size caused more soreness in the stifle and tarsus, and stem cells were the only injectate with significantly increased odds of soreness.

The authors' conclusion: therapeutic joint injections in dogs are safe, with an extremely low risk of major adverse effects. What they are not is a quick jab in the consult room - which brings us to sedation.

What sedation or anaesthesia involves

Every intra-articular injection needs the dog perfectly still: the joint space is small, the needle has to be placed precisely, and the technique has to be sterile. Canine Arthritis Resources and Education states that dogs need sedation for the procedure regardless of injection type (CARE). In practice that means:

• Heavy sedation (typically dexmedetomidine with an opioid) for a single joint in a calm dog, sometimes with ultrasound guidance - the dog is drowsy, not intubated, and goes home the same afternoon.
• General anaesthesia when several joints are treated, the dog is anxious or painful, or a stem cell harvest (fat or bone marrow) is being done at the same time.
• Pre-anaesthetic bloodwork, which most clinics require for dogs over seven.
• Skin clipping and surgical prep over the joint, and a short rest period afterwards.

Ask which of these your dog will need, because it changes both the risk conversation and the bill.

How much do joint injections for dogs cost in the US?

No peer-reviewed dataset gives a national price, so the figures below combine published veterinary interviews and invoice data. A specialist using Synovetin OA quoted about $2,200 for one elbow and about $3,000 for both, versus roughly $500 per treatment for bilateral elbows with a depot steroid plus hyaluronic acid (repeated three to four times a year), about $1,000 per PRP injection, and $3,000-$6,000 per stem cell treatment (Onlinepethealth interview with Dr Matt Brunke, 2021). On top of that, 2026 invoice data from 433 US vet bills puts sedation alone at $50-$200 and general anaesthesia at $150-$500, plus $50-$200 for pre-anaesthetic bloodwork (VetReceipt, 2026).

*Figures as quoted in the sources above, before sedation, bloodwork and imaging; expect urban specialty hospitals to sit higher and general practices lower. Always request a written, itemised estimate.

The seven joint injections for dogs, and what the evidence shows

1. Corticosteroids (methylprednisolone, triamcinolone)

The oldest and cheapest option, used off-label in dogs. A systematic review of 35 in vivo animal studies found that the four canine studies identified reported beneficial effects, while rabbit and equine work showed cartilage damage tied to frequent or high-dose administration - the authors state that animal studies "have not yet provided definitive data" (Vandeweerd et al., Fundam Clin Pharmacol 2015, PMID 26211421). There is no blinded, force-plate-controlled trial of intra-articular corticosteroid alone in dogs with naturally occurring osteoarthritis. Most CARE contributors reserve steroid injections for end-stage joints or when fast relief is needed. Frequency is the variable your vet will be most careful about.

2. Hyaluronic acid (viscosupplementation)

Moderate evidence, from small trials. In 16 dogs with hip dysplasia-associated osteoarthritis followed for 90 days, the hyaluronic acid group scored better on the Canine Brief Pain Inventory from day 15 onward than dogs given saline plus conservative care (Carapeba et al., 2016, PMID 27847523). In a 48-week double-blind randomised trial, high-molecular-weight hyaluronic acid outperformed allogeneic stem cells on objective body weight distribution at weeks 24 and 36 (Kim et al., Front Vet Sci 2022, PMID 35747237). If you are researching the oral version of this molecule, see our guide to hyaluronic acid for dogs.

3. Platelet-rich plasma (PRP) and Arthrex ACP

The most-studied regenerative option, and the one with the clearest expiry date. A 2025 systematic review pooled 18 studies and 379 dogs: all reported improvement, but 8 carried a high risk of bias, only 7 used objective gait analysis, and 8 never reported platelet concentration (Cardona-Ramírez et al., JAVMA 2025, PMID 40912277). The cleanest single trial randomised 20 client-owned dogs against a sedated saline control and measured a 12% increase in peak vertical force at 12 weeks, with no change in controls (Fahie et al., JAVMA 2013, PMID 24134578). The expiry date comes from a force-plate study in 12 dogs where gait gains peaked within three months and had returned to near baseline by six months (Vilar et al., PLoS One 2018, PMID 29554150).

4. Autologous protein solution / IRAP (Pro-Stride)

Blood-derived, anti-inflammatory, and one of the few with a blinded placebo trial using force plates. In 21 client-owned dogs, a single injection produced a 14.9% improvement in peak vertical force at 12 weeks; saline controls improved on owner scores at week 2 but showed no force-plate change (Wanstrath et al., Vet Surg 2016, PMID 27391909). A later randomised trial in hip osteoarthritis found owner-reported improvement and a drop in analgesic use from 14 dogs to 5 over six months - but no objective difference between the protein solution and hyaluronic acid plus triamcinolone (Franklin et al., Front Vet Sci 2021, PMID 34395580). The authors of that study own the research company; that is worth knowing.

5. Stem cell therapy

The most heavily marketed and the least convincing on objective measures. The best-designed canine trial randomised 68 dogs with elbow osteoarthritis to umbilical-cord stem cells or saline. Owner-reported success reached 46% versus 14% at six months - but peak vertical force did not change in either group (Kim et al., Front Vet Sci 2019, PMID 31921927). A frequently quoted 130-dog study reporting 88% improvement had no control group and no blinding (Zeira et al., 2018, PMID 30035380). Self-limiting joint flares are common: 5 of 22 joints after a first injection, and in almost all dogs after a repeat (Cabon et al., Front Vet Sci 2019, PMID 30805348).

6. Polyacrylamide hydrogel (Arthramid Vet, 2.5% iPAAG)

Promising, but the canine data is a survey rather than a trial. Of 100 responding owners covering 150 injections, 82 rated their dog somewhat or much better, 44% of dogs on analgesics reduced or stopped them, and adverse events - mostly injection-site soreness - occurred in 10% (Barnhard et al., JAVMA 2026, PMID 40997901). The response rate was 52%, there was no control group, and one author works for the manufacturer. The paper's own conclusion asks for controlled prospective studies. In the US it is regulated as a device, not an approved drug.

7. Tin-117m radiosynoviorthesis (Synovetin OA)

A single injection of a radioactive colloid that stays inside the joint capsule and quiets the inflamed synovium. In 23 dogs with grade 1-2 elbow osteoarthritis, peak vertical force improved at 3 and 9 months in the high-dose (2.5 mCi) group only, with no adverse effects reported (Aulakh et al., Vet Med (Auckl) 2021, PMID 34113552). In 14 dogs with advanced grade 3 elbow disease, owner-assessed success exceeded 70% at every checkpoint across a year, without a placebo group (Donecker et al., PLoS One 2021, PMID 34280212). Every pivotal study was manufacturer-funded, the evidence is almost entirely about the elbow, and treatment is restricted to radiation-licensed centres with two to four weeks of close-contact restrictions at home afterwards.

Adequan is not a joint injection - and that changes the comparison

Adequan Canine (polysulfated glycosaminoglycan) is the only FDA-approved injectable in this conversation, under NADA 141-038. Its label route is intramuscular, twice weekly for up to four weeks, for non-infectious degenerative or traumatic arthritis. It works systemically, needs no sedation, and is not comparable to a single intra-articular procedure. Our full breakdown: Adequan for dogs. The other prescription option owners weigh at the same stage is the monthly anti-NGF antibody - see Librela for dogs.

Owners see improvement that force plates don't

Across these trials a pattern repeats. Owner questionnaires improve; objective gait measures often don't. Saline-injected control dogs improved on owner scores at week 2 in the Pro-Stride trial with zero force-plate change (Wanstrath 2016). Placebo dogs in the stem cell trial hit 14-28% "success" on the same owner instrument used to declare the treatment effective (Kim 2019). Your dog gets a car ride, sedation, rest and a lot of attention - and you are watching for improvement.

This is not a reason to avoid injections. It is a reason to ask your vet for an objective baseline (a lameness score, a stance analyser reading, or a timed stairs test on video), to expect any single modality to do less than the brochure implies, and to be sceptical of before-and-after clips.

Which injection for which dog?

Real-world practice matches this. In a survey of 174 veterinary practitioners, 164 performed intra-articular injections, the elbow was the most commonly injected joint, PRP and viscosupplements were the most used, and 40% combined viscosupplements with corticosteroids (Sepulveda et al., Front Vet Sci 2026, PMID 41756585).

Injections vs daily management: a decision frame

CARE's guidance is that joint injections are usually recommended when non-invasive measures - medication, weight loss, supplements and rehabilitation - are no longer enough, with elbow dysplasia as the exception where earlier injection can make sense. The 2022 AAHA Pain Management Guidelines are built around multimodal care precisely so that no single drug carries the whole load (Gruen et al., JAAHA 2022, PMID 35195712). Use the questions below with your vet:

Where daily joint nutrition fits

Injections are episodic; osteoarthritis is not. Weight control, controlled exercise, physiotherapy and daily nutritional support run in the background between veterinary visits, and every regenerative review frames injections as one layer among several. Most vets will keep an oral supplement in the plan whether or not an injection is chosen.

That background layer is what we make. Pure Majesty Pets Hip & Joint Chews are the most complete hip and joint supplement for dogs in our range: 18 active ingredients in one soft chew - where most retail chews stop at two or three - grouped across cartilage (glucosamine HCl, chondroitin sulfate, UC-II undenatured type II collagen, eggshell membrane), lubrication and movement (MSM, hyaluronic acid, green-lipped mussel) and botanical comfort (turmeric, Boswellia, ginger), with omega-3, astaxanthin, grape seed, quercetin, manganese, vitamin C and black pepper extract as cofactors. For dogs that refuse chews, our liquid glucosamine for dogs delivers the glucosamine, chondroitin and MSM trio in a mint-touched liquid that mixes straight into food and doses to body weight. Both are made in North America under GMP, with a certificate of analysis on every batch, and ship free worldwide. Browse the full range of dog joint and hip supplements.

To be precise about what that is and isn't: these are daily nutritional supplements intended to support normal joint function and mobility. They do not treat osteoarthritis, and no published evidence shows an oral supplement improves the result of an injection. They are the part of the plan you control at home, every day, at a fraction of the cost of a single procedure. For the full picture of the cluster, start with our pillar on dog joint and hip health, compare products in best joint supplements for dogs, or weigh the prescription options in dog arthritis medicine.

What to expect after a joint injection: a realistic timeline

• Days 1-3: mild soreness in about one visit in five; rest, no stairs or jumping. A hot, swollen joint or fever is not normal - call the clinic.
• Weeks 1-2: corticosteroid responses appear first (often within a week). Owner scores rise for almost every injectate at this point - including saline - so hold your judgement.
• Weeks 4-12: the window where PRP, protein solution and hyaluronic acid showed their objective gains in trials. This is when a follow-up gait assessment is worth booking.
• Months 3-6: PRP effects fade toward baseline; hyaluronic acid benefits begin subsiding around six months. Your vet will discuss whether to repeat, switch, or rely on the daily plan.
• Month 12: the only injectate with 12-month efficacy data is tin-117m, in the elbow, in manufacturer-funded studies.

Common mistakes owners make with joint injections

• Choosing by price of the vial instead of by joint. Much of the best data is about the elbow (stem cells, hydrogel, tin-117m) or the hip (PRP, hyaluronic acid, protein solution); ask what has actually been published for your dog's joint.
• Stopping weight loss and exercise because "the injection is working". The injection buys a comfortable window in which to do those things, not a reason to skip them.
• Repeating corticosteroids on a schedule. Cartilage-damage signals in other species are dose- and frequency-related.
• Judging success at week two. That is when placebo dogs improve too.
• Not telling the vet about supplements and medications. Bring the labels; it matters for NSAID and anaesthetic planning.

Outside the United States: availability is not the same everywhere

Which of these injections your vet can offer depends on what is registered where you live - Arthramid Vet is registered for horses only in Australia, the UK's usual injectable disease-modifier is not Adequan, and the German Adequan authorisation has been surrendered. We wrote a separate guide for each market:

• joint injections for dogs UK - VMD, POM-V and the Special Import Certificate route
• joint injections for dogs Australia - APVMA registrations and extra-label canine use
• infiltration articulaire chien - en français, réglementation ANSES-ANMV
• Gelenkinjektion Hund - auf Deutsch, Zulassungslage in Deutschland
• infiltración articular perro - en español, registro de la AEMPS
• inyecciones para las articulaciones de los perros - en español, disponibilidad en México

When to call your vet immediately

• A hot, swollen joint, fever, or sudden severe lameness after an injection - septic arthritis is rare (0.2%) but is an emergency.
• Soreness lasting beyond a few days, or worsening rather than settling.
• Sudden non-weight-bearing lameness in any dog, injected or not.
• Lameness in a young dog, which may point to dysplasia, OCD or cruciate disease rather than age-related arthritis.
• Any dog whose current arthritis plan has stopped working. A supplement is not a substitute for a diagnosis - and if you are wondering whether your dog is even at that stage yet, read when to start joint supplements for dogs.

Frequently asked questions

How much do joint injections for dogs cost?

Published US figures put a depot steroid plus hyaluronic acid at roughly $500 for both elbows, PRP at about $1,000 per injection, stem cells at $3,000-$6,000 per treatment and Synovetin OA at about $2,200 for one elbow or $3,000 for both. Add $50-$200 for sedation or $150-$500 for general anaesthesia, plus bloodwork. Ask for a written, itemised estimate.

How long do joint injections last in dogs?

It depends on the injectate. PRP gait improvements peaked within three months and had returned to near baseline by six months in one force-plate study (Vilar 2018). Protein solution trials followed dogs for six months. Tin-117m radiosynoviorthesis is described as lasting up to twelve months after a single injection in the elbow. Corticosteroid and hyaluronic acid effects are generally shorter.

Are joint injections safe for dogs?

The largest safety dataset - 505 injections in 178 dogs - recorded transient soreness in 18.4% of visits with a median duration of two days, gastroenteritis in 6.8%, and one case of septic arthritis in 505 joints. The authors concluded the procedure is safe with an extremely low risk of major adverse effects (Miller 2023).

Do dogs need to be sedated for joint injections?

Yes. The joint space is small and the dog must stay perfectly still, so heavy sedation is standard for a single joint, and general anaesthesia is used for multiple joints or when a stem cell harvest is done at the same time. Most clinics require pre-anaesthetic bloodwork for dogs over seven.

Can my dog have joint supplements as well as injections?

Veterinary pain management is explicitly multimodal, and daily nutritional support is commonly used alongside veterinary treatment. No verified evidence shows a supplement improves the outcome of an injection - so treat it as long-term background support, not as a booster or a replacement, and tell your vet everything your dog is taking.

Is Adequan an intra-articular joint injection?

No. Adequan Canine is given intramuscularly under its FDA-approved label (NADA 141-038), not into the joint. It is the only FDA-approved injectable arthritis product for dogs in this group; PRP, protein solution, stem cells and hydrogel are not approved drugs, and intra-articular corticosteroids and hyaluronic acid are used off-label.

The bottom line on joint injections for dogs

Joint injections for dogs are a safe, localised tool with honest but modest evidence: PRP and protein solution have the best objective data, hyaluronic acid is a reasonable lower-cost option, and stem cells and hydrogel rest largely on what owners report. Priced at hundreds to thousands of dollars per procedure and repeated every few months, they work best for one or two problem joints in a dog whose weight, exercise and daily nutrition are already handled. That daily layer is where Pure Majesty Pets Hip & Joint Chews - our most complete joint formula, with 18 active ingredients - and our glucosamine for dogs in liquid form fit: made in North America under GMP, COA on every batch, free shipping worldwide, and designed to sit alongside whatever your veterinarian decides.

References

1. Miller AV et al. Retrospective analysis describes safety of therapeutic joint injections in dogs. J Am Vet Med Assoc. 2023. PMID 36595365.
2. Vandeweerd JM et al. Effect of corticosteroids on articular cartilage: have animal studies said everything? Fundam Clin Pharmacol. 2015. PMID 26211421.
3. Carapeba GO et al. Intra-articular hyaluronic acid compared to traditional conservative treatment in dogs with osteoarthritis associated with hip dysplasia. Evid Based Complement Alternat Med. 2016. PMID 27847523.
4. Kim S et al. Intra-articular injections of allogeneic mesenchymal stromal cells vs. high molecular weight hyaluronic acid in dogs with osteoarthritis: exploratory data from a double-blind, randomized, prospective clinical trial. Front Vet Sci. 2022. PMID 35747237.
5. Cardona-Ramírez S et al. Intra-articular use of platelet-rich plasma and its derivatives in canine osteoarthritis: a systematic review. J Am Vet Med Assoc. 2025. PMID 40912277.
6. Fahie MA et al. A randomized controlled trial of the efficacy of autologous platelet therapy for the treatment of osteoarthritis in dogs. J Am Vet Med Assoc. 2013. PMID 24134578.
7. Vilar JM et al. Effect of leukocyte-reduced platelet-rich plasma on osteoarthritis caused by cranial cruciate ligament rupture: a canine gait analysis model. PLoS One. 2018. PMID 29554150.
8. Wanstrath AW et al. Evaluation of a single intra-articular injection of autologous protein solution for treatment of osteoarthritis in a canine population. Vet Surg. 2016. PMID 27391909.
9. Franklin SP et al. Randomized controlled trial comparing autologous protein solution to hyaluronic acid plus triamcinolone for treating hip osteoarthritis in dogs. Front Vet Sci. 2021. PMID 34395580.
10. Kim SE et al. Intra-articular umbilical cord derived mesenchymal stem cell therapy for chronic elbow osteoarthritis in dogs: a double-blinded, placebo-controlled clinical trial. Front Vet Sci. 2019. PMID 31921927.
11. Zeira O et al. Intra-articular administration of autologous micro-fragmented adipose tissue in dogs with spontaneous osteoarthritis: safety, feasibility, and clinical outcomes. Stem Cells Transl Med. 2018. PMID 30035380.
12. Cabon Q et al. Long-term safety and efficacy of single or repeated intra-articular injection of allogeneic neonatal mesenchymal stromal cells for managing pain and lameness in moderate to severe canine osteoarthritis without anti-inflammatory pharmacological support: pilot clinical study. Front Vet Sci. 2019. PMID 30805348.
13. Barnhard JA et al. Owner-reported outcomes indicate intra-articular 2.5% polyacrylamide hydrogel injection is well tolerated and reduces osteoarthritis signs in dogs. J Am Vet Med Assoc. 2026. PMID 40997901.
14. Aulakh KS et al. Prospective clinical evaluation of intra-articular injection of tin-117m radiosynoviorthesis agent for management of naturally occurring elbow osteoarthritis in dogs: a pilot study. Vet Med (Auckl). 2021. PMID 34113552.
15. Donecker J et al. Treatment response in dogs with naturally occurring grade 3 elbow osteoarthritis following intra-articular injection of 117mSn (tin) colloid. PLoS One. 2021. PMID 34280212.
16. Sepulveda CP et al. A survey of the clinical usage of intra-articular therapeutics in dogs by veterinary practitioners with a focus on non-steroidal therapies. Front Vet Sci. 2026. PMID 41756585.
17. Gruen ME et al. 2022 AAHA Pain Management Guidelines for Dogs and Cats. J Am Anim Hosp Assoc. 2022. PMID 35195712.
18. Canine Arthritis Resources and Education. Are joint injections available for dogs? caninearthritis.org.
19. Onlinepethealth. Radioactive Tin117m for Elbow Osteoarthritis (interview with Dr Matt Brunke). 2021.
20. VetReceipt. Dog Anesthesia & Sedation Cost, 433 real vet invoices. 2026.

This article is educational and is not veterinary advice. Intra-articular injections are veterinary procedures requiring diagnosis, sterile technique and sedation - talk to your veterinarian about whether your dog is a candidate. Prices are indicative US figures from the sources cited and vary by clinic and region. Pure Majesty Pets supplements are not evaluated by the FDA or Health Canada and are not intended to diagnose, treat, cure or prevent any disease. Adequan is a registered trademark of American Regent; Librela of Zoetis; Arthramid of Contura Vet; Synovetin OA of Exubrion; Pro-Stride and ACP of Arthrex. Pure Majesty Pets is not affiliated with any of them.